1. Abelson, J., F. Wagner, D. DeJean, et al. 2016. Public and patient involvement in health technology assessment. International Journal of Technology Assessment in Health Care 32(4): 256–264.
2. Aggarwal, A., T. Fojo, C. Chamberlain, C. Davis, and R. Sullivan. 2017. Do patient access schemes for high-cost cancer drugs deliver value to society?—Lessons from the NHS Cancer Drugs Fund. Annals of Oncology 28(8): 1738–1750.
3. Australian Commission on Safety and Quality in Health Care. 2008. Australian Charter of Healthcare Rights. https://www.safetyandquality.gov.au/wp-content/uploads/2012/01/Charter-PDf.pdf. Accessed April 8, 2019.
4. Australian Commission on Safety and Quality in Health Care. 2014. Partnering with consumers: Embedding partnerships in health care. https://www.safetyandquality.gov.au/wp-content/uploads/2014/11/Partnering-with-Consumers-Embedding-partnerships-in-health-care.pdf.
5. CADTH. 2017. pan-Canadian Oncology Drug Review patient engagement guide. https://cadth.ca/sites/default/files/pcodr/pCODR%27s%20Drug%20Review%20Process/pcodr-patient-engagement-guide.pdf.